Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Arjo AB ( ($SE:ARJO.B) ) has shared an update.
Arjo AB has released its 2025 Annual and Sustainability Report, detailing its performance, targets, and results alongside its strategic focus on capturing value from global megatrends driving increased care needs. The report bundles financial statements, risk analysis, and corporate governance disclosures with a statutory sustainability report prepared under the Swedish Annual Accounts Act and European Sustainability Reporting Standards, underscoring Arjo’s commitment to transparent governance and sustainable healthcare practices.
The publication also outlines board and management structures, remuneration, and proposed profit appropriation, providing investors and stakeholders with a comprehensive view of the company’s oversight and capital allocation. By integrating audited sustainability, environmental, social, and governance disclosures into its annual reporting framework, Arjo reinforces its positioning as a leading mobility specialist in healthcare and signals its intent to align long-term growth with regulatory demands and responsible business conduct.
The most recent analyst rating on ($SE:ARJO.B) stock is a Hold with a SEK27.00 price target. To see the full list of analyst forecasts on Arjo AB stock, see the SE:ARJO.B Stock Forecast page.
More about Arjo AB
Arjo AB is a Swedish-based healthcare company specializing in medical equipment and solutions that support patient mobility, safe handling, and related care workflows. The company focuses on improving clinical outcomes and efficiency in care environments, with a growing emphasis on sustainability and compliance with European reporting standards.
Average Trading Volume: 635,206
Technical Sentiment Signal: Sell
Current Market Cap: SEK6.8B
For a thorough assessment of ARJO.B stock, go to TipRanks’ Stock Analysis page.

